REG - Aviva PLC - Admission to Trading

AvivaAnnouncement

28/05/2026 14:45

For best results when printing this announcement, please click on link below:
https://newsfile.refinitiv.com/getnewsfile/v1/story?guid=urn:newsml:reuters.com:20260528:nRSb1087Ga&default-theme=true

RNS Number : 1087G  Aviva PLC  28 May 2026

 

 

28 May 2026

 

 

 

Admission to trading of Aviva plc's €575,000,000 Tier 2 Fixed to Floating
Rate Notes due November 2057

 

Aviva plc's (the "Company") €575,000,000 Tier 2 Fixed to Floating Rate Notes
due November 2057 (ISIN: XS3318828012) (the "Notes") have been admitted to the
Official List of the Financial Conduct Authority (the "FCA") and to trading on
the Main Market of the London Stock Exchange on 28 May 2026.

 

The Notes were issued by the Company under its £7,000,000,000 Euro Note
Programme (the "Programme") updated on 11 March 2026. The Final Terms are
available for viewing at
http://www.rns-pdf.londonstockexchange.com/rns/1087G_3-2026-5-28.pdf
(http://www.rns-pdf.londonstockexchange.com/rns/1087G_3-2026-5-28.pdf) .

 

The Final Terms should be read in conjunction with the Base Prospectus dated
11 March 2026 prepared in respect of the Programme (the "Prospectus"), as
supplemented by a Supplemental Prospectus dated 15 May 2026 (the "Supplemental
Prospectus"). The Prospectus (which was approved by the FCA on 11 March 2026)
is available for viewing at
http://www.rns-pdf.londonstockexchange.com/rns/1087G_1-2026-5-28.pdf
(http://www.rns-pdf.londonstockexchange.com/rns/1087G_1-2026-5-28.pdf) , and
the Supplemental Prospectus (which was approved by the FCA on 15 May 2026) is
available for viewing at
http://www.rns-pdf.londonstockexchange.com/rns/1087G_2-2026-5-28.pdf
(http://www.rns-pdf.londonstockexchange.com/rns/1087G_2-2026-5-28.pdf) .

 

The Company's LEI is YF0Y5B0IB8SM0ZFG9G81.

 

-ends-

 

 

Enquiries:

 

  Media:

  Andrew Reid               +44 (0)7800 694 276
  Sarah Swailes             +44 (0)7800 694 859

  Investors and Analysts:

  Greg Neilson              +44 (0)7800 694 564

 

 

This announcement does not constitute or form part of an offer to sell or the
solicitation of an offer to subscribe for or otherwise acquire any securities.

 

The securities referred to herein have not been and will not be registered
under the U.S. Securities Act of 1933, as amended (the "Securities Act"), or
with any securities regulatory authority of any State or other jurisdiction of
the United States, and are subject to Unites States tax law requirements.
Subject to certain exceptions, the securities referred to herein may not be
offered, sold or delivered in the United States (as defined in Regulation S
under the Securities Act) or to, or for the account or benefit of, U.S.
persons (as defined in the U.S. Internal Revenue Code of 1986, as amended, and
regulations thereunder). Neither the Prospectus nor the Supplementary
Prospectus may be accessed from, or transmitted in or into, the United States.
Accordingly, these securities may not be offered, sold or delivered in the
United States.

 

Please note that the information contained in the Supplemental Prospectus and
the Prospectus may be addressed to and/or targeted at persons who are
residents of particular countries (specified in the Prospectus) only and is
not intended for use and should not be relied upon by any person outside these
countries and/or to whom the offer contained in the Prospectus is not
addressed.  Prior to relying on the information contained in the Supplemental
Prospectus or the Prospectus you must ascertain from the Prospectus whether or
not you are part of the intended addressees of the information contained
therein.

 

Your right to access this service is conditional upon complying with the above
requirements.

 

 

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact
rns@lseg.com (mailto:rns@lseg.com)
 or visit
www.rns.com (http://www.rns.com/)
.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our
Privacy Policy (https://www.lseg.com/privacy-and-cookie-policy)
.   END  ADMEADSPADEKEFA



            Copyright 2019 Regulatory News Service, all rights reserved